| UniProt ID | CEP55_HUMAN | |
|---|---|---|
| UniProt AC | Q53EZ4 | |
| Protein Name | Centrosomal protein of 55 kDa {ECO:0000312|HGNC:HGNC:1161} | |
| Gene Name | CEP55 {ECO:0000312|HGNC:HGNC:1161} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 464 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cleavage furrow . Midbody, Midbody ring . Present at the centrosomes at interphase. A sma | |
| Protein Description | Plays a role in mitotic exit and cytokinesis. [PubMed: 16198290] | |
| Protein Sequence | MSSRSTKDLIKSKWGSKPSNSKSETTLEKLKGEIAHLKTSVDEITSGKGKLTDKERHRLLEKIRVLEAEKEKNAYQLTEKDKEIQRLRDQLKARYSTTTLLEQLEETTREGERREQVLKALSEEKDVLKQQLSAATSRIAELESKTNTLRLSQTVAPNCFNSSINNIHEMEIQLKDALEKNQQWLVYDQQREVYVKGLLAKIFELEKKTETAAHSLPQQTKKPESEGYLQEEKQKCYNDLLASAKKDLEVERQTITQLSFELSEFRRKYEETQKEVHNLNQLLYSQRRADVQHLEDDRHKTEKIQKLREENDIARGKLEEEKKRSEELLSQVQFLYTSLLKQQEEQTRVALLEQQMQACTLDFENEKLDRQHVQHQLHVILKELRKARNQITQLESLKQLHEFAITEPLVTFQGETENREKVAASPKSPTAALNESLVECPKCNIQYPATEHRDLLVHVEYCSK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MSSRSTKDLIKS ---CCCCCHHHHHHH | 41.58 | 24719451 | |
| 6 | Ubiquitination | --MSSRSTKDLIKSK --CCCCCHHHHHHHH | 27.71 | 22817900 | |
| 11 | Ubiquitination | RSTKDLIKSKWGSKP CCHHHHHHHHCCCCC | 53.96 | 21890473 | |
| 13 | Ubiquitination | TKDLIKSKWGSKPSN HHHHHHHHCCCCCCC | 51.04 | 29967540 | |
| 16 | Phosphorylation | LIKSKWGSKPSNSKS HHHHHCCCCCCCCCC | 40.03 | 27470641 | |
| 17 | Ubiquitination | IKSKWGSKPSNSKSE HHHHCCCCCCCCCCH | 48.83 | 29967540 | |
| 19 | Phosphorylation | SKWGSKPSNSKSETT HHCCCCCCCCCCHHH | 58.43 | 25002506 | |
| 21 | Phosphorylation | WGSKPSNSKSETTLE CCCCCCCCCCHHHHH | 41.73 | 25002506 | |
| 22 | Ubiquitination | GSKPSNSKSETTLEK CCCCCCCCCHHHHHH | 57.47 | 33845483 | |
| 23 | Phosphorylation | SKPSNSKSETTLEKL CCCCCCCCHHHHHHH | 39.74 | 30576142 | |
| 25 | Phosphorylation | PSNSKSETTLEKLKG CCCCCCHHHHHHHHH | 43.71 | 25002506 | |
| 26 | Phosphorylation | SNSKSETTLEKLKGE CCCCCHHHHHHHHHH | 28.94 | 25002506 | |
| 27 | Ubiquitination | NSKSETTLEKLKGEI CCCCHHHHHHHHHHH | 7.73 | 21890473 | |
| 29 | Ubiquitination | KSETTLEKLKGEIAH CCHHHHHHHHHHHHH | 59.62 | 33845483 | |
| 31 | Ubiquitination | ETTLEKLKGEIAHLK HHHHHHHHHHHHHHH | 66.61 | 21906983 | |
| 31 (in isoform 1) | Ubiquitination | - | 66.61 | 21890473 | |
| 31 (in isoform 2) | Ubiquitination | - | 66.61 | 21890473 | |
| 32 | Ubiquitination | TTLEKLKGEIAHLKT HHHHHHHHHHHHHHC | 41.81 | 22817900 | |
| 38 | Ubiquitination | KGEIAHLKTSVDEIT HHHHHHHHCCHHHHH | 28.96 | 29967540 | |
| 39 | Phosphorylation | GEIAHLKTSVDEITS HHHHHHHCCHHHHHC | 40.10 | 23312004 | |
| 40 | Phosphorylation | EIAHLKTSVDEITSG HHHHHHCCHHHHHCC | 26.45 | 23312004 | |
| 45 | Phosphorylation | KTSVDEITSGKGKLT HCCHHHHHCCCCCCC | 29.40 | 27470641 | |
| 48 | Acetylation | VDEITSGKGKLTDKE HHHHHCCCCCCCHHH | 53.27 | 26051181 | |
| 48 | Ubiquitination | VDEITSGKGKLTDKE HHHHHCCCCCCCHHH | 53.27 | 32015554 | |
| 52 | Phosphorylation | TSGKGKLTDKERHRL HCCCCCCCHHHHHHH | 48.81 | - | |
| 64 | Ubiquitination | HRLLEKIRVLEAEKE HHHHHHHHHHHHHHH | 37.73 | 22817900 | |
| 66 | Ubiquitination | LLEKIRVLEAEKEKN HHHHHHHHHHHHHHC | 3.56 | 22817900 | |
| 72 | Ubiquitination | VLEAEKEKNAYQLTE HHHHHHHHCHHHCCH | 58.93 | 33845483 | |
| 75 | Phosphorylation | AEKEKNAYQLTEKDK HHHHHCHHHCCHHHH | 17.28 | 28060719 | |
| 92 | Ubiquitination | QRLRDQLKARYSTTT HHHHHHHHHHHHHHH | 25.78 | - | |
| 95 | Phosphorylation | RDQLKARYSTTTLLE HHHHHHHHHHHHHHH | 18.41 | 30576142 | |
| 96 | Phosphorylation | DQLKARYSTTTLLEQ HHHHHHHHHHHHHHH | 17.45 | 24719451 | |
| 97 | Phosphorylation | QLKARYSTTTLLEQL HHHHHHHHHHHHHHH | 18.18 | 27251275 | |
| 98 | Phosphorylation | LKARYSTTTLLEQLE HHHHHHHHHHHHHHH | 14.98 | 30576142 | |
| 99 | Phosphorylation | KARYSTTTLLEQLEE HHHHHHHHHHHHHHH | 29.45 | 30576142 | |
| 119 | Ubiquitination | ERREQVLKALSEEKD HHHHHHHHHHHHCHH | 48.72 | 29967540 | |
| 125 | Ubiquitination | LKALSEEKDVLKQQL HHHHHHCHHHHHHHH | 49.43 | 22817900 | |
| 129 | Ubiquitination | SEEKDVLKQQLSAAT HHCHHHHHHHHHHHH | 35.53 | - | |
| 129 | Ubiquitination | SEEKDVLKQQLSAAT HHCHHHHHHHHHHHH | 35.53 | 22817900 | |
| 129 (in isoform 1) | Ubiquitination | - | 35.53 | 21890473 | |
| 129 (in isoform 2) | Ubiquitination | - | 35.53 | 21890473 | |
| 133 | Phosphorylation | DVLKQQLSAATSRIA HHHHHHHHHHHHHHH | 16.12 | 29514088 | |
| 136 | Phosphorylation | KQQLSAATSRIAELE HHHHHHHHHHHHHHH | 20.46 | 29514088 | |
| 137 | Phosphorylation | QQLSAATSRIAELES HHHHHHHHHHHHHHH | 19.57 | 29514088 | |
| 144 | Phosphorylation | SRIAELESKTNTLRL HHHHHHHHHCCCEEH | 58.36 | 29514088 | |
| 145 | Ubiquitination | RIAELESKTNTLRLS HHHHHHHHCCCEEHH | 36.10 | - | |
| 145 | Ubiquitination | RIAELESKTNTLRLS HHHHHHHHCCCEEHH | 36.10 | 22817900 | |
| 145 (in isoform 1) | Ubiquitination | - | 36.10 | 21890473 | |
| 145 (in isoform 2) | Ubiquitination | - | 36.10 | 21890473 | |
| 146 | Phosphorylation | IAELESKTNTLRLSQ HHHHHHHCCCEEHHC | 42.59 | - | |
| 148 | Phosphorylation | ELESKTNTLRLSQTV HHHHHCCCEEHHCCC | 20.63 | - | |
| 152 | Phosphorylation | KTNTLRLSQTVAPNC HCCCEEHHCCCCCCC | 19.85 | 27080861 | |
| 154 | Phosphorylation | NTLRLSQTVAPNCFN CCEEHHCCCCCCCCC | 18.43 | 25159151 | |
| 162 | Phosphorylation | VAPNCFNSSINNIHE CCCCCCCCCCCCHHE | 16.61 | 27080861 | |
| 163 | Phosphorylation | APNCFNSSINNIHEM CCCCCCCCCCCHHEE | 30.36 | 27080861 | |
| 175 | Ubiquitination | HEMEIQLKDALEKNQ HEEEEHHHHHHHHHC | 25.28 | 22817900 | |
| 180 | Ubiquitination | QLKDALEKNQQWLVY HHHHHHHHHCCEEEE | 61.99 | - | |
| 180 | Ubiquitination | QLKDALEKNQQWLVY HHHHHHHHHCCEEEE | 61.99 | 22817900 | |
| 180 (in isoform 1) | Ubiquitination | - | 61.99 | 21890473 | |
| 180 (in isoform 2) | Ubiquitination | - | 61.99 | 21890473 | |
| 187 | Phosphorylation | KNQQWLVYDQQREVY HHCCEEEEHHHHHHH | 13.08 | 27642862 | |
| 196 | Ubiquitination | QQREVYVKGLLAKIF HHHHHHHHHHHHHHH | 26.59 | - | |
| 196 | Ubiquitination | QQREVYVKGLLAKIF HHHHHHHHHHHHHHH | 26.59 | 21890473 | |
| 196 (in isoform 1) | Ubiquitination | - | 26.59 | 21890473 | |
| 196 (in isoform 2) | Ubiquitination | - | 26.59 | 21890473 | |
| 198 | Ubiquitination | REVYVKGLLAKIFEL HHHHHHHHHHHHHHH | 3.31 | 22505724 | |
| 201 | Ubiquitination | YVKGLLAKIFELEKK HHHHHHHHHHHHHHH | 48.15 | 21906983 | |
| 201 (in isoform 1) | Ubiquitination | - | 48.15 | 21890473 | |
| 201 (in isoform 2) | Ubiquitination | - | 48.15 | 21890473 | |
| 207 | 2-Hydroxyisobutyrylation | AKIFELEKKTETAAH HHHHHHHHHHHHHHH | 77.08 | - | |
| 207 | Ubiquitination | AKIFELEKKTETAAH HHHHHHHHHHHHHHH | 77.08 | 32015554 | |
| 208 | Ubiquitination | KIFELEKKTETAAHS HHHHHHHHHHHHHHC | 42.07 | 29967540 | |
| 215 | Phosphorylation | KTETAAHSLPQQTKK HHHHHHHCCCCCCCC | 36.70 | 30576142 | |
| 220 | Phosphorylation | AHSLPQQTKKPESEG HHCCCCCCCCCCCCC | 35.47 | 30576142 | |
| 221 | Ubiquitination | HSLPQQTKKPESEGY HCCCCCCCCCCCCCC | 63.09 | 32015554 | |
| 222 | Ubiquitination | SLPQQTKKPESEGYL CCCCCCCCCCCCCCC | 58.36 | 32015554 | |
| 225 | Phosphorylation | QQTKKPESEGYLQEE CCCCCCCCCCCCHHH | 44.86 | 28851738 | |
| 228 | Phosphorylation | KKPESEGYLQEEKQK CCCCCCCCCHHHHHH | 10.93 | 29978859 | |
| 229 | Ubiquitination | KPESEGYLQEEKQKC CCCCCCCCHHHHHHH | 8.32 | 22817900 | |
| 233 | Acetylation | EGYLQEEKQKCYNDL CCCCHHHHHHHHHHH | 55.06 | 26051181 | |
| 233 | Ubiquitination | EGYLQEEKQKCYNDL CCCCHHHHHHHHHHH | 55.06 | 21906983 | |
| 233 (in isoform 1) | Ubiquitination | - | 55.06 | 21890473 | |
| 233 (in isoform 2) | Ubiquitination | - | 55.06 | 21890473 | |
| 235 | Ubiquitination | YLQEEKQKCYNDLLA CCHHHHHHHHHHHHH | 50.16 | 22817900 | |
| 237 | Phosphorylation | QEEKQKCYNDLLASA HHHHHHHHHHHHHHH | 20.81 | 27642862 | |
| 243 | Phosphorylation | CYNDLLASAKKDLEV HHHHHHHHHHHCHHH | 40.36 | 21815630 | |
| 245 | Ubiquitination | NDLLASAKKDLEVER HHHHHHHHHCHHHHH | 44.30 | 32015554 | |
| 246 | Ubiquitination | DLLASAKKDLEVERQ HHHHHHHHCHHHHHH | 68.23 | - | |
| 268 | Ubiquitination | ELSEFRRKYEETQKE HHHHHHHHHHHHHHH | 53.40 | 29967540 | |
| 269 | Phosphorylation | LSEFRRKYEETQKEV HHHHHHHHHHHHHHH | 19.72 | 23403867 | |
| 272 | Phosphorylation | FRRKYEETQKEVHNL HHHHHHHHHHHHHHH | 32.76 | 23403867 | |
| 274 | Ubiquitination | RKYEETQKEVHNLNQ HHHHHHHHHHHHHHH | 69.95 | 29967540 | |
| 284 | Phosphorylation | HNLNQLLYSQRRADV HHHHHHHHHHHHHHH | 16.02 | 29978859 | |
| 285 | Phosphorylation | NLNQLLYSQRRADVQ HHHHHHHHHHHHHHH | 19.72 | 29978859 | |
| 300 | Ubiquitination | HLEDDRHKTEKIQKL HHHCCHHHHHHHHHH | 60.31 | 29967540 | |
| 303 | Ubiquitination | DDRHKTEKIQKLREE CCHHHHHHHHHHHHH | 56.52 | 29967540 | |
| 306 | Ubiquitination | HKTEKIQKLREENDI HHHHHHHHHHHHCCH | 53.65 | 29967540 | |
| 317 | Ubiquitination | ENDIARGKLEEEKKR HCCHHHCHHHHHHHH | 47.36 | 29967540 | |
| 336 | Phosphorylation | LSQVQFLYTSLLKQQ HHHHHHHHHHHHHHH | 8.79 | 22461510 | |
| 337 | Phosphorylation | SQVQFLYTSLLKQQE HHHHHHHHHHHHHHH | 18.29 | 22461510 | |
| 338 | Phosphorylation | QVQFLYTSLLKQQEE HHHHHHHHHHHHHHH | 20.39 | 24719451 | |
| 341 | Ubiquitination | FLYTSLLKQQEEQTR HHHHHHHHHHHHHHH | 56.05 | - | |
| 360 | Phosphorylation | EQQMQACTLDFENEK HHHHHHHCCCCCCCH | 32.17 | - | |
| 367 | Ubiquitination | TLDFENEKLDRQHVQ CCCCCCCHHHHHHHH | 68.23 | 32015554 | |
| 396 | Phosphorylation | NQITQLESLKQLHEF HHHHHHHHHHHHHHH | 49.84 | 27067055 | |
| 398 | Ubiquitination | ITQLESLKQLHEFAI HHHHHHHHHHHHHHC | 61.16 | 22817900 | |
| 398 (in isoform 1) | Ubiquitination | - | 61.16 | 21890473 | |
| 425 | Phosphorylation | NREKVAASPKSPTAA CHHHHCCCCCCCCHH | 24.11 | 25159151 | |
| 427 | Ubiquitination | EKVAASPKSPTAALN HHHCCCCCCCCHHHC | 67.58 | 29967540 | |
| 428 | Phosphorylation | KVAASPKSPTAALNE HHCCCCCCCCHHHCH | 30.76 | 19664994 | |
| 430 | Phosphorylation | AASPKSPTAALNESL CCCCCCCCHHHCHHH | 31.49 | 22167270 | |
| 436 | Phosphorylation | PTAALNESLVECPKC CCHHHCHHHCCCCCC | 36.32 | 19664994 | |
| 442 | Ubiquitination | ESLVECPKCNIQYPA HHHCCCCCCCCCCCC | 52.12 | 29967540 | |
| 461 | Phosphorylation | DLLVHVEYCSK---- CEEEEHHCCCC---- | 10.84 | 29978859 | |
| 463 | Phosphorylation | LVHVEYCSK------ EEEHHCCCC------ | 40.26 | 29978859 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 425 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
| 425 | S | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
| 428 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
| 428 | S | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
| 436 | S | Phosphorylation | Kinase | PLK1 | P53350 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CEP55_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TS101_HUMAN | TSG101 | physical | 17853893 | |
| VP37B_HUMAN | VPS37B | physical | 17853893 | |
| VP37C_HUMAN | VPS37C | physical | 17853893 | |
| PDC6I_HUMAN | PDCD6IP | physical | 17853893 | |
| TS101_HUMAN | TSG101 | physical | 17556548 | |
| PDC6I_HUMAN | PDCD6IP | physical | 17556548 | |
| CEP55_HUMAN | CEP55 | physical | 17556548 | |
| PDC6I_HUMAN | PDCD6IP | physical | 18948538 | |
| TS101_HUMAN | TSG101 | physical | 18948538 | |
| NBR1_HUMAN | NBR1 | physical | 21909099 | |
| CEP55_HUMAN | CEP55 | physical | 25416956 | |
| PKHG6_HUMAN | PLEKHG6 | physical | 25416956 | |
| RBM22_HUMAN | RBM22 | physical | 25416956 | |
| RCOR3_HUMAN | RCOR3 | physical | 25416956 | |
| EIF1A_HUMAN | EIF1AD | physical | 25416956 | |
| MUM1_HUMAN | MUM1 | physical | 25416956 | |
| SPF45_HUMAN | RBM17 | physical | 25416956 | |
| FBF1_HUMAN | FBF1 | physical | 25416956 | |
| MISSL_HUMAN | MAPK1IP1L | physical | 25416956 | |
| HAUS1_HUMAN | HAUS1 | physical | 25416956 | |
| ADIP_HUMAN | SSX2IP | physical | 25416956 | |
| CCBE1_HUMAN | CCBE1 | physical | 25416956 | |
| CE57L_HUMAN | CEP57L1 | physical | 25416956 | |
| TGO1_HUMAN | MIA3 | physical | 25416956 | |
| PEF1_HUMAN | PEF1 | physical | 25416956 | |
| TEAD4_HUMAN | TEAD4 | physical | 21516116 | |
| MTMR4_HUMAN | MTMR4 | physical | 27432908 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425; SER-428; THR-430AND SER-436, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425; SER-428; THR-430AND SER-436, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-425 AND SER-428, ANDMASS SPECTROMETRY. | |
| "Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosomeprotein, Cep55, is required for its recruitment to midbody andcytokinesis."; Fabbro M., Zhou B.-B., Takahashi M., Sarcevic B., Lal P., Graham M.E.,Gabrielli B.G., Robinson P.J., Nigg E.A., Ono Y., Khanna K.K.; Dev. Cell 9:477-488(2005). Cited for: FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITHPLK1; AKAP9 AND PCNT, PHOSPHORYLATION AT SER-425; SER-428 AND SER-436,MUTAGENESIS OF SER-396; SER-425; SER-428 AND SER-436, AND MASSSPECTROMETRY. | |